Documentos relacionados

1. Issues associated with possible implementation of Non-Invasive Prenatal Testing (NIPT) in first-tier screening: A rapid scoping review.
2. Does isolated nuchal translucency from 2.5 to 2.9 mm increase the risk of fetal chromosome disease?
3. Clinician views and experiences of non-invasive prenatal genetic screening tests in Australia.
4. Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study.
5. [Detection rate and clinical significance of regions of homozygosity in prenatal genetic diagnosis].
6. A new and improved method of library preparation for non-invasive prenatal testing: plasma to library express technology.
7. Receiving uncertain results from prenatal chromosomal microarray analysis: Women's decisions on continuation or termination of pregnancy.
8. Reproductive deliberation: Supporting autonomous decision making in prenatal genetic counseling.
9. Ethical issues associated with prenatal screening using non-invasive prenatal testing for sex chromosome aneuploidy.
10. Current practice of first-trimester ultrasound screening for structural fetal anomalies in developed countries.